Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Postoperative Analgesia in Thoracoscopic Surgery
NCT05458453Phase 4Completed
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Jul 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postoperative pain (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: Minute ventilation volume, Tidal volume and 1 more. Started Jul 2022; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05458453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05458453.